Anthea Pharma – Excellence Beyond Manufacturing
Anthea Pharma is a young and fast-growing company — aiming to operate as a global CDMO injectable manufacturing firm. We are in the process of establishing a comprehensive infrastructure for injectable development with cutting-edge manufacturing capabilities, and a streamlined execution process to address substantial obstacles and unmet demands in the pharmaceutical injectable space.
At Anthea we develop and manufacture ready-to-use injectable molecules that are of highest quality, safety and ease of use. Our supply chain is streamlined, risk and expense of technology transfers are decreased, and production and delivery times are tightened.
Research and Development
Our capability spans over the development of different injectables such as Vials, Emulsions, Lyophilized Vials and Prefilled Syringes (PFS), lyophilized drugs and more. Anthea’s aim is to invest in formulation, production, technology, and process development in a way that delivers results which are par excellence. We are well-equipped for development and commercialization, with a strong commitment to quality, compliance, and customer service.
With such a large market to serve, we are looking forward to a journey full of opportunity, hard effort, and success.
Anthea Pharma is in process to set a new standard in the pharmaceutical sector by becoming a benchmark in injectable manufacturing. Our state-of-the-art injectable plant will pave the way for leading injectable scientists, chemists, pharmacies, and engineers and help them achieve their goal. This advanced manufacturing plant is intelligently built to incorporate the most innovative maintenance practices in order to minimize batch loss during product changeover and improve the overall efficiency of the production cycle.
Equipped with cutting-edge technology, we are expected to become one of the best plants globally.
Global CDMO – Quality, Delivery & Reliability
Anthea’s highly trained formulation technicians ensure that your product is manufactured in accordance with cGMP and global standards. Ensuring batch-to-batch consistency in order to achieve product specifications and maintain regulatory compliance.
It is Anthea’s mission to help you bring your injectable drug product to the market.
Why Choose Us?
Work with a partner that makes you the priority
“Commitment is a standard operating procedure for us. We maintain transparency and ensure fairness in our collaborations.”
With the goal of manufacturing for the entire world and becoming a global CDMO firm focused on injectables needs, Anthea Pharma envisions to provide consistent supply of the highest-quality products across therapeutic segments to customers around the world.
With 5 Manufacturing Lines and based on cutting-edge research and technology our infrastructure is designed to develop 30-40 molecules every year. We aim to establish ourselves as a major player in the pharmaceutical CDMO market, both in our home country and around the world.
Contract Development & Manufacturing
Integrated development and manufacturing of injectables for the healthcare and pharmaceutical industries. We have a dedicated in-house analytical development department managed by experienced professionals. Our core team is dedicated to the creation of injectables of the highest possible quality and efficacy.
Our quality systems comprise of Manufacturing Execution System (MES), Quality Management System, Laboratory Management system (LMS) and SAP System.
Critical & Complex Injectables
Manufacturing products that are difficult to formulate, filter and fill. Provide solutions and manufacture Injectable products that are complex. Our scaled up facility utilizes the best-in class technologies to bridge R&D and manufacturing through process optimization & characterization.
Regulatory Support and Marketing
R&D facility is designed for development, formulations & supporting analytical methods. Supported by dedicated regulatory and project management services.